Real-time enrollment status for this urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:38 PM UTC
| NCT Number | NCT06396533 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 92 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Fox Chase Cancer Center |
| Last Updated on CT.gov | October 31, 2025 (Oct 31, 2025) |
As of July 16, 2026: Clinical trial NCT06396533 is currently recruiting participants. This clinical trial study for urothelial carcinoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Fox Chase Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06396533 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06396533 was last updated Oct 31, 2025 (October 31, 2025). HelloStudys verifies this status automatically.